1. Home
  2. BIOA vs TZOO Comparison

BIOA vs TZOO Comparison

Compare BIOA & TZOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIOA
  • TZOO
  • Stock Information
  • Founded
  • BIOA 2015
  • TZOO 1998
  • Country
  • BIOA United States
  • TZOO United States
  • Employees
  • BIOA N/A
  • TZOO N/A
  • Industry
  • BIOA Biotechnology: Pharmaceutical Preparations
  • TZOO Advertising
  • Sector
  • BIOA Health Care
  • TZOO Consumer Discretionary
  • Exchange
  • BIOA Nasdaq
  • TZOO Nasdaq
  • Market Cap
  • BIOA 155.2M
  • TZOO 136.1M
  • IPO Year
  • BIOA 2024
  • TZOO 2002
  • Fundamental
  • Price
  • BIOA $4.55
  • TZOO $9.94
  • Analyst Decision
  • BIOA Hold
  • TZOO Strong Buy
  • Analyst Count
  • BIOA 4
  • TZOO 4
  • Target Price
  • BIOA $5.67
  • TZOO $23.50
  • AVG Volume (30 Days)
  • BIOA 91.6K
  • TZOO 187.6K
  • Earning Date
  • BIOA 08-06-2025
  • TZOO 07-23-2025
  • Dividend Yield
  • BIOA N/A
  • TZOO N/A
  • EPS Growth
  • BIOA N/A
  • TZOO N/A
  • EPS
  • BIOA N/A
  • TZOO 0.90
  • Revenue
  • BIOA $3,863,000.00
  • TZOO $87,822,000.00
  • Revenue This Year
  • BIOA N/A
  • TZOO $14.30
  • Revenue Next Year
  • BIOA N/A
  • TZOO $15.42
  • P/E Ratio
  • BIOA N/A
  • TZOO $11.10
  • Revenue Growth
  • BIOA N/A
  • TZOO 3.47
  • 52 Week Low
  • BIOA $2.88
  • TZOO $9.41
  • 52 Week High
  • BIOA $26.62
  • TZOO $24.85
  • Technical
  • Relative Strength Index (RSI)
  • BIOA N/A
  • TZOO 37.89
  • Support Level
  • BIOA N/A
  • TZOO $9.56
  • Resistance Level
  • BIOA N/A
  • TZOO $10.69
  • Average True Range (ATR)
  • BIOA 0.00
  • TZOO 0.44
  • MACD
  • BIOA 0.00
  • TZOO 0.08
  • Stochastic Oscillator
  • BIOA 0.00
  • TZOO 37.32

About BIOA BioAge Labs Inc. Common Stock

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

About TZOO Travelzoo

Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment, which is the key revenue driver, consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; and New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties.

Share on Social Networks: